Markets:

Overview

News

Currencies

International

Treasuries

Mereo BioPharma Group plc - American Depositary Shares (NQ:MREO)

0.4477 -0.0242 (-5.13%)

Streaming Delayed Price Updated: 1:21 PM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Mereo BioPharma Group plc - American Depositary Shares

< Previous 1 2 3 4 Next >

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

January 12, 2026

Via Chartmill

Keep an eye on the top gainers and losers in Monday's session. ↗

January 12, 2026

Via Chartmill

Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗

January 06, 2026

Via Chartmill

Unusual volume stocks are being observed in Tuesday's session. ↗

January 06, 2026

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

January 06, 2026

Via Chartmill

These stocks have an unusual volume in today's session ↗

January 05, 2026

Via Chartmill

In today's session, these stocks are experiencing unusual volume. ↗

January 02, 2026

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

December 31, 2025

Via Chartmill

Unusual volume stocks in Wednesday's session ↗

December 31, 2025

Via Chartmill

In today's session, these stocks are experiencing unusual volume. ↗

December 30, 2025

Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session.

Via Chartmill

Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal

December 29, 2025

The biopharmaceutical sector witnessed a dramatic surge in volatility today, December 29, 2025, as the industry careened toward the end of its strongest year in two decades. In a day defined by extreme...

Via MarketMinute

Topics ETFs Intellectual Property

Which stocks are most active on Monday? ↗

December 29, 2025

Stay updated with the latest market activity on Monday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.

Via Chartmill

Mereo BioPharma Group Plc (NASDAQ:MREO) Beats Q3 2025 EPS Estimates, Maintains Cash Runway into 2027 ↗

November 10, 2025

Mereo BioPharma (MREO) beat Q3 EPS estimates with a narrower loss. The clinical-stage company has cash into 2027 and key data for its lead drug expected soon.

Via Chartmill

Ultragenyx Represents 'Intriguing Buying Opportunity,' Despite Recent Setbacks ↗

July 28, 2025

HC Wainwright initiates Ultragenyx at Buy with $80 target, citing strong rare disease pipeline and late-stage data expected by year-end.

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

July 10, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 10, 2025

Via Benzinga

Crude Oil Down Over 2%; Delta Air Lines Posts Upbeat Earnings ↗

July 10, 2025

Via Benzinga

Which stocks are experiencing notable movement on Thursday? ↗

July 10, 2025

Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

US Stocks Mixed; Initial Jobless Claims Fall ↗

July 10, 2025

Via Benzinga

Ultragenyx, Mereo Hammered For Their Surprise Miss In Brittle Bone Disease ↗

July 10, 2025

The study will continue onto a third and final analysis toward the end of the year.

Via Investor's Business Daily

Thursday's session: gap up and gap down stocks ↗

July 10, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Ultragenyx, Mereo Shares Dive As Brittle Bone Disease Drug Misses Early Win ↗

July 10, 2025

Ultragenyx shares fall after Phase 3 study misses interim target, but analysts remain positive ahead of final OI data expected later this year.

Via Benzinga

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

July 10, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 10, 2025

Via Benzinga

Methode Electronics, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

July 10, 2025

Via Benzinga

Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket ↗

July 10, 2025

Via Benzinga

Ultragenyx, Mereo Sink After Hours As Bone Drug Trial Continues Without Early Stop; Retail Traders Feel Selloff Is Overdone ↗

July 10, 2025

The companies now expect final data from the Orbit and Cosmic studies by the end of the year.

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 09, 2025

Via Benzinga

What's going on in today's after hours session ↗

July 09, 2025

Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

Rio Tinto, Bumble And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

June 03, 2025

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.